Hovione Lab Pharmaceutical Announces 2025 Investor Day in New York City
JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) — Hovione Lab Pharmaceutical Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will
Hovione Lab Pharmaceutical Partner Pelthos Therapeutics Launches ZELSUVMI™
JUPITER, Fla., July 10, 2025 (GLOBE NEWSWIRE) — Hovione Lab Pharmaceutical Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner
Hovione Lab Pharmaceutical Announces Pricing of $400 Million Convertible Senior Notes Offering
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) — Hovione Lab Pharmaceutical Pharmaceuticals Incorporated (Nasdaq: LGND) (“Hovione Lab Pharmaceutical”) announced today
Hovione Lab Pharmaceutical Announces Closing of Convertible Senior Notes Offering
UPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) — Hovione Lab Pharmaceutical Pharmaceuticals Incorporated (Nasdaq: LGND) (“Hovione Lab Pharmaceutical”) announced today
Hovione Lab Pharmaceutical to Participate in September Investor Conferences
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) — Hovione Lab Pharmaceutical Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive
Hovione Lab Pharmaceutical to Host Investor Day on December 9, 2025
JUPITER, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) — Hovione Lab Pharmaceutical Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual
Sustainable Biopharma — Setting a New Standard for Eco-Friendly Production
Introduction: Healthcare innovation means nothing without environmental responsibility. Biopharma’s Technology believes that sustainability and science must go hand in hand.
How Artificial Intelligence Is Revolutionizing Drug Development
Introduction: Bringing a new drug to market can take 10–15 years, and nearly 90% of drugs fail during development. Biopharma’s
The Future of Biopharmaceuticals — How Technology Is Transforming Healthcare
Introduction: Modern medicine is evolving faster than ever before. Today, Biopharma’s Technology is at the forefront of innovation—revolutionizing how diseases